OPGN logo

OpGen, Inc. (OPGN)

Profile

Full Name

OpGen, Inc.

Ticker

NASDAQ: OPGN

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

May 5, 2015

Indexes

Not included

Website

http://www.opgen.com

Employees

85

Key Details

Price

$0.04(0.00%)

Market cap

$392.66K(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.42M(+31.10% YoY)

Annual EPS

-$41.47(+72.84% YoY)

PE ratio

-

Next earnings date

Jul 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.04
    OPGN price is $0.04

    30-Day Relative Volume

    0.00
    OPGN 30-day relative volume is 0.00

    Price Performance

    Price Most recent change

    0%
    OPGN price has remained unchanged on Jul 25, 2025

    Price YTD change

    -93.45%
    OPGN price is down -93.45% since January 1st

    Price 1-year change

    -98.73%
    OPGN price is down -98.73% year-on-year

    Price 3-year change

    -99.96%
    OPGN price is down -99.96% over the past 3 years

    Price Range

    Price All-time high

    $544000.00
    OPGN price is currently -100.00% below its historical high of $544000.00

    Price 3-year low

    $0.04
    OPGN price is currently at its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $392.66K
    OPGN market capitalization is $392.66 thousand

    Market cap 3-year change

    -98.31%
    OPGN market capitalization is down -98.31% over the past 3 years

    Market cap All-time high

    $137.04M
    OPGN market capitalization is currently -99.71% below its historical high of $137.04 million

    Market cap sector rank

    3.22%
    OPGN market capitalization is higher than 3.22% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +646.34%
    OPGN shares outstanding is up +646.34% year-on-year

    Shares Outstanding 3-Year Change

    +4219.22%
    OPGN shares outstanding is up +4219.22% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -0.25
    OPGN beta is -0.25

    200-day SMA

    $2.66
    OPGN price is currently -98.53% below its 200-day simple moving average

    50-day SMA

    $4.47
    OPGN price is currently -99.13% below its 50-day simple moving average

    RSI

    13.18
    OPGN 14-day relative strength index is 13.18

    Volume

    0.00
    OPGN 30-day relative volume is 0.00

    ATR

    $0.52
    OPGN average true range is $0.52

    10-day Historical Volatility

    509.83%
    OPGN 10-day historical volatility is 509.83%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $3.42M
    OPGN annual revenue is $3.42 million

    Revenue Analysts estimate

    $2.60M
    OPGN annual revenue is currently +31.47% higher than the consensus analysts' forecast

    Revenue 1-year change

    +31.1%
    OPGN annual revenue is up +31.1% year-on-year

    Revenue Sector rank

    18.63%
    OPGN annual revenue is higher than 18.63% of companies in Healthcare sector

    EPS

    EPS

    -$41.47
    OPGN annual earnings per share is -$41.47

    EPS Analysts estimate

    -
    OPGN annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    +72.84%
    OPGN annual earnings per share is up +72.84% year-on-year

    EPS Sector rank

    4.81%
    OPGN annual earnings per share is higher than 4.81% of companies in Healthcare sector

    Profit

    Gross profit

    -$90.70K
    OPGN annual gross profit is -$90.70 thousand

    Gross margin

    -2.65%
    OPGN annual gross profit margin is -2.65%

    Operating profit

    -$15.69M
    OPGN annual operating income is -$15.69 million

    Operating margin

    -458.95%
    OPGN annual operating profit margin is -458.95%

    Net income

    -$32.67M
    OPGN annual net profit is -$32.67 million

    Net margin

    -955.69%
    OPGN annual net profit margin is -955.69%

    Expenses

    Total expenses

    $19.11M
    OPGN annual total expenses is $19.11 million

    Operating expenses

    $15.60M
    OPGN annual total operating expenses is $15.60 million

    Cost of goods sold

    $3.51M
    OPGN annual cost of goods sold is $3.51 million

    Selling, general & administrative expenses

    $10.86M
    OPGN annual SGA is $10.86 million

    Depreciation and amortization

    $1.32M
    OPGN annual depreciation & amortization is $1.32 million

    Interest expense

    $1.84M
    OPGN annual interest expense is $1.84 million

    Income tax

    $0.00
    OPGN annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$30.83M
    OPGN annual earnings before interest & taxes is -$30.83 million

    EBITDA

    -$29.51M
    OPGN annual EBITDA is -$29.51 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.88M
    OPGN annual total assets is $1.88 million

    Non current assets

    $302.40K
    OPGN annual long term assets is $302.40 thousand

    Current assets

    $1.58M
    OPGN annual total current assets is $1.58 million

    Cash and cash equivalents

    $1.15M
    OPGN annual cash & cash equivalents is $1.15 million

    Accounts receivable

    $103.30K
    OPGN annual accounts receivable is $103.30 thousand

    Inventory

    $0.00
    OPGN annual inventory is $0.00

    Liabilities

    Total liabilities

    $13.44M
    OPGN annual total liabilities is $13.44 million

    Long term liabilities

    $2.02M
    OPGN annual total long term liabilities is $2.02 million

    Current liabilities

    $11.42M
    OPGN annual total current liabilities is $11.42 million

    Accounts payable

    $111.10K
    OPGN annual accounts payable is $111.10 thousand

    Debt

    Total debt

    $13.04M
    OPGN annual total debt is $13.04 million

    Total debt 1-year change

    -12%
    OPGN annual total debt is down -12% year-on-year

    Long term debt

    $2.02M
    OPGN annual long term debt is $2.02 million

    Short term debt

    $11.02M
    OPGN annual short term debt is $11.02 million

    Equity & Capital

    Shareholders equity

    -$11.56M
    OPGN annual stockholders equity is -$11.56 million

    Book value

    -$11.56M
    OPGN annual book value is -$11.56 million

    Retained earnings

    -$305.49M
    OPGN annual retained earnings is -$305.49 million

    Working capital

    -$9.84M
    OPGN annual working capital is -$9.84 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$14.32M
    OPGN annual cash flow from operations is -$14.32 million

    Cash from operations 1-year change

    +29.98%
    OPGN annual cash flow from operations is up +29.98% year-on-year

    Cash from investing

    -$800.40K
    OPGN annual cash flow from investing activities is -$800.40 thousand

    Cash from investing 1-year change

    -35.48%
    OPGN annual cash flow from investing activities is down -35.48% year-on-year

    Cash from financing

    $8.37M
    OPGN annual cash flow from financing activities is $8.37 million

    Cash from financing 1-year change

    +224.31%
    OPGN annual cash flow from financing activities is up +224.31% year-on-year

    CAPEX

    CAPEX

    $800.40K
    OPGN annual capital expenditures is $800.40 thousand

    CAPEX 1-year change

    +35.48%
    OPGN annual capital expenditures is up +35.48% year-on-year

    Free Cash Flow

    Free cash flow

    -$15.12M
    OPGN annual free cash flow is -$15.12 million

    Free cash flow 1-year change

    +28.14%
    OPGN annual free cash flow is up +28.14% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -2.65%
    OPGN annual gross profit margin is -2.65%

    Operating margin

    -458.95%
    OPGN annual operating profit margin is -458.95%

    Net margin

    -955.69%
    OPGN annual net profit margin is -955.69%

    ROA & ROE

    ROA

    -235.91%
    OPGN annual return on assets is -235.91%

    ROE

    282.56%
    OPGN annual return on equity is 282.56%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    OPGN price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    OPGN price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.13
    OPGN price to book ratio is 0.13

    PB ratio Sector rank

    17.78%
    OPGN price to book ratio is higher than 17.78% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    OPGN price to sales ratio value is unknown

    PS ratio Sector rank

    -
    OPGN price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $1.00M
    OPGN enterprise value is $1.00 million

    Enterprise value Sector rank

    11.51%
    OPGN enterprise value is higher than 11.51% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.11
    OPGN EV/EBITDA is -0.11

    EV/EBITDA Sector rank

    64.79%
    OPGN EV/EBITDA is higher than 64.79% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.14
    OPGN annual current ratio is 0.14

    Quick ratio

    0.14
    OPGN annual quick ratio is 0.14

    Leverage

    Debt to equity

    -0.94
    OPGN annual debt to equity ratio is -0.94

    Interest coverage ratio

    -16.77
    OPGN annual interest coverage ratio is -16.77

    Risk & Stability

    Piotroski F-Score

    -
    OPGN piotroski f-score value is unknown

    Altman Z-Score

    -285.71
    OPGN altman z-score is -285.71

    Analyst ratings

    Recent major analysts updates

    Aug 14, 23 HC Wainwright & Co.
    Neutral
    Jul 20, 23 HC Wainwright & Co.
    Buy
    Jun 26, 23 HC Wainwright & Co.
    Buy
    Jun 21, 23 HC Wainwright & Co.
    Buy
    May 16, 23 HC Wainwright & Co.
    Buy
    May 13, 22 HC Wainwright & Co.
    Buy
    Mar 2, 21 Alliance Global Partners
    Buy
    Nov 25, 20 Rodman & Renshaw
    Buy
    Jun 29, 16 Rodman & Renshaw
    Buy

    Institutional Ownership

    Screeners with OPGN included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for OpGen, Inc.?
    • Does OpGen, Inc. pay dividends?
    • What sector is OpGen, Inc. in?
    • What industry is OpGen, Inc. in?
    • What country is OpGen, Inc. based in?
    • When did OpGen, Inc. go public?
    • Is OpGen, Inc. in the S&P 500?
    • Is OpGen, Inc. in the NASDAQ 100?
    • Is OpGen, Inc. in the Dow Jones?
    • When was OpGen, Inc.'s last earnings report?
    • When does OpGen, Inc. report earnings?

    What is the ticker symbol for OpGen, Inc.?

    The ticker symbol for OpGen, Inc. is NASDAQ:OPGN

    Does OpGen, Inc. pay dividends?

    No, OpGen, Inc. does not pay dividends

    What sector is OpGen, Inc. in?

    OpGen, Inc. is in the Healthcare sector

    What industry is OpGen, Inc. in?

    OpGen, Inc. is in the Medical Devices industry

    What country is OpGen, Inc. based in?

    OpGen, Inc. is headquartered in United States

    When did OpGen, Inc. go public?

    OpGen, Inc.'s initial public offering (IPO) was on May 5, 2015

    Is OpGen, Inc. in the S&P 500?

    No, OpGen, Inc. is not included in the S&P 500 index

    Is OpGen, Inc. in the NASDAQ 100?

    No, OpGen, Inc. is not included in the NASDAQ 100 index

    Is OpGen, Inc. in the Dow Jones?

    No, OpGen, Inc. is not included in the Dow Jones index

    When was OpGen, Inc.'s last earnings report?

    OpGen, Inc.'s most recent earnings report was on November 15, 2024

    When does OpGen, Inc. report earnings?

    The next expected earnings date for OpGen, Inc. is July 29, 2025
    On this page